# Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Unpacking a 17.65% Potential Upside in the Healthcare Sector

- Link: https://www.directorstalkinterviews.com/cross-country-healthcare-inc-ccrn-stock-analysis-unpacking-a-17-65-potential-upside-in-the-healthcare-sector/4121245649
- Published: 2026-03-20T11:31:52+00:00
- Author: Madison Wilson

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands as a noteworthy player in the
healthcare sector, specifically within the niche of medical care facilities. Headquartered
in Boca Raton, Florida, the company specializes in talent management services, offering
a range of staffing solutions across the United States. With a market capitalization
of $306.31 million, Cross Country Healthcare is not the largest entity in the sector,
but it holds a significant position due to its comprehensive service offerings.

The current stock price of CCRN is $9.35, reflecting a slight change of 0.49 (0.06%).
Over the past 52 weeks, the stock has seen a price range between $7.53 and $15.11,
indicating some volatility but also potential for recovery and growth. The average
target price set by analysts stands at $11.00, suggesting a potential upside of 
17.65% from its current price, which could be appealing to value-driven investors
looking for opportunities in the healthcare staffing industry.

However, investors should approach with caution, as the company’s financial metrics
present a mixed bag. The forward P/E ratio of 32.38 raises questions about the stock’s
valuation, especially given the absence of trailing P/E, price/book, and price/sales
ratios, which leaves some uncertainty regarding its market positioning. The company’s
revenue growth has seen a decline of 23.60%, and its earnings per share (EPS) is
at a concerning -2.93. Moreover, a return on equity of -25.57% further emphasizes
the challenges CCRN faces in terms of profitability.

On a more positive note, Cross Country Healthcare reports a free cash flow of $42.77
million, providing a cushion for operations and potential investments in business
expansions or improvements. The company does not currently offer a dividend, maintaining
a payout ratio of 0.00%, which might be an indication of a strategic choice to reinvest
earnings into growth initiatives.

Analyst ratings reflect a cautious stance, with 2 buy ratings and 7 hold ratings.
Notably, there are no sell ratings, which could imply confidence in the company’s
potential to overcome its current hurdles. The target price range from analysts 
spans from $10.00 to $14.00, suggesting a broad spectrum of expectations regarding
its future performance.

Technical indicators provide additional insights into the stock’s current state.
The 50-day moving average of $8.90 points to recent upward movement, although it
remains below the 200-day moving average of $11.33, indicating that the stock has
been underperforming over the longer term. The Relative Strength Index (RSI) of 
44.95 positions the stock in the neutral zone, though leaning slightly towards being
oversold, and the MACD reading of 0.14 against a signal line of 0.19 suggests a 
cautious bullish sentiment.

Cross Country Healthcare’s business model, which spans nurse and allied staffing
as well as physician staffing, positions it to serve a diverse range of healthcare
facilities—from acute care hospitals to government facilities and outpatient clinics.
This diversity can be a strong asset in navigating the ever-evolving healthcare 
landscape, particularly as the demand for healthcare professionals continues to 
fluctuate.

Investors considering CCRN should weigh the potential upside against the company’s
current financial challenges and the broader economic factors impacting the healthcare
sector. As the company navigates these complexities, its ability to leverage its
free cash flow and expand its service offerings will be crucial in determining its
trajectory in the coming months.

Share on: